Most Popular in:
Medical Esthetics Treatments
FDA Investigates Consumer Knowledge of Dermal Fillers' Safety
Posted: November 25, 2008
page 2 of 2
The panel concluded that the FDA should communicate the risk of long-lasting reactions to the consumers and doctors, according to the Associated Press. "This is almost a no-brainer," said panel member Michael Bigby, MD, a Harvard Medical School dermatologist, quoted in the Associated Press. "The current label is not adequate." The panel also agreed on the need for more safety studies.
An FDA-assembled panel will also be discussing the regulation of dermatology devices such as low-level light therapy and lasers. The regulatory body will be asking the panel for advice on how to evaluate the effectiveness of low level energy devices.
CosmeticsDesign.com, Nov.19, 2008